Clinical Trials Logo

Clinical Trial Summary

Regarding oral cavity cancer, the high incidence of neck metastasis along with its impact on survival and prognosis are in favor of elective neck dissection. Moreover, occult metastases could develop at lower levels in the neck (levels IV-V) Regarding the tongue, the rate of skip (occult) metastasis involving unremoved level IV cervical lymph nodes in squamous cell carcinoma of the tongue ranges from 0 % - 11.4 %. However, no data is available or a correlation between the risk of level IV involvement and the affection of specific tongue subsites or a certain cutoff value of tumor thickness.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06169605
Study type Interventional
Source Cairo University
Contact Mohamed Shawky, MSc
Phone +201223933897
Email m.shawky1993@gmail.com
Status Not yet recruiting
Phase N/A
Start date December 20, 2023
Completion date December 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT03239834 - Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making
Not yet recruiting NCT03288298 - Therapeutic Effect Of Luteolin Natural Extract Versus Its Nanoparticles On Tongue Squamous Cell Carcinoma Cell Line Early Phase 1
Recruiting NCT02584270 - Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue N/A
Completed NCT01195922 - Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma Phase 1/Phase 2
Recruiting NCT02985255 - Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral Tongue Phase 2